Clinical research - Press Releases

Date	Title	Company
21-Jul-2023	The Science-Based Targets Initiative (SBTi) validates Almirall's 2030 emission reduction targets and its goal of achieving net zero emissions by 2050	Almirall
21-Jul-2023	Teva UK launches GoResp® Digihaler® (budesonide/ formoterol), the first integrated digital inhaler system for appropriate adult patients with asthma and COPD[i] in the UK	Teva UK Limited
21-Jul-2023	Researchers aim for rapid biomarker diagnostic test for stroke, using saliva	University of Birmingham
21-Jul-2023	HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study	HUTCHMED
21-Jul-2023	Healthcasts Introduces ConsensusAI, the First AI-Powered, Real-Time Patient Consultation Tool for Healthcare Professionals	Healthcasts
20-Jul-2023	Triastek Reports Positive FIH Results from Study of T21, a 3D Printed Oral Treatment for Moderate to Severe Ulcerative Colitis	Triastek
19-Jul-2023	[Press Release] SMART researchers uncover novel bacterial communication system to combat antimicrobial resistance	Blue Totem Communications
18-Jul-2023	AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer	AARDEX Group
18-Jul-2023	ClinChoice Acquires CROMSOURCE, Solidifying its Position Globally	ClinChoice
17-Jul-2023	EnteroBiotix appoints Elmar Schnee as Executive Chairman	EnteroBiotix
17-Jul-2023	Santen launches Roclanda®, with the ROCK inhibitor netarsudil, in the UK – representing the first new class of medication for the medical management of glaucoma in Europe in 25 years	Santen
14-Jul-2023	New Business Support Programme and Competition for Life Science Startups: Discovery Spark	Discovery Spark
14-Jul-2023	BC Platforms Advances BC\|RQUEST to Revolutionize Drug Discovery and Development	BC\|RQUEST
14-Jul-2023	Revvity Establishes Scientific Centre of Excellence for Genomic Insight in Cambridge	Revvity
12-Jul-2023	New AI drug discovery collaboration aims to design new precision cancer drugs	The Institute of Cancer Research
12-Jul-2023	Dr. Dominik Kugelstadt joins Rentschler Biopharma as Head of Clinical and Commercial Manufacturing, Laupheim	Rentschler Biopharma
12-Jul-2023	EDX MEDICAL GROUP PLC ANNOUNCES ERIK JENSEN AS COMMERCIAL DIRECTOR, UK & NORTHERN EUROPE	EDX Medical Group
12-Jul-2023	Guaranteeing Solid Clinical Exploration	TechnoBridge
11-Jul-2023	Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements	Skyelarke
11-Jul-2023	Phastar's B Corp™ certification affirms its status as a 'force for good' organization	Phastar